21/02/2026
Regenerative Treatments for Empty Nose Syndrome | Microfat, Nanofat, SVF & MFAT
https://www.ent-istanbul.com/2026/02/regenerative-strategies-in-empty-nose-microfat-nanofat-svf-microfragmanted-fat.html
Empty Nose Syndrome (ENS) is one of the most challenging conditions in rhinology. Despite an objectively wide nasal airway, patients experience paradoxical nasal obstruction, dryness, air hunger, and severe impairment in quality of life. ENS is not simply a problem of airflow—it represents a complex interaction between turbinate volume loss, mucosal atrophy, microvascular damage, fibrosis, and neurosensory dysfunction.
In recent years, autologous adipose tissue–based regenerative therapies have gained increasing attention as potential treatment options for ENS. Unlike synthetic implants or purely structural solutions, fat-derived approaches aim to restore both anatomical volume and biological function of the nasal mucosa.
This short video provides a concise, clinically focused comparison of four major adipose-derived techniques used in ENS management:
Microfat is primarily a volume-restoring technique. By preserving viable adipocytes, microfat injections can partially recreate turbinate bulk and help redirect nasal airflow. However, its regenerative capacity is limited, and graft survival depends heavily on local vascularity.
Nanofat contains minimal viable adipocytes but is rich in stromal cells, growth factors, and cytokines. Its primary role in ENS is not volume replacement, but improvement of mucosal quality, angiogenesis, and tissue remodeling—making it particularly useful in atrophic and fibrotic nasal mucosa.
Stromal Vascular Fraction (SVF) represents the most cell-rich option, containing adipose-derived stem cells, pericytes, endothelial progenitor cells, and immune-modulating cells. SVF offers strong regenerative and anti-inflammatory potential, but provides little structural support and faces regulatory and standardization challenges.
Microfragmented Fat Tissue (MFAT) bridges the gap between structure and biology. By preserving adipocytes, stromal cells, and extracellular matrix in a minimally manipulated form, MFAT offers both volume stability and regenerative support. This hybrid nature makes MFAT especially attractive in selected ENS patients with combined volume loss and mucosal degeneration.
This video highlights the advantages, limitations, and clinical roles of each technique, emphasizing that no single method is universally curative. ENS treatment must be individualized, often requiring a multimodal strategy that balances airflow mechanics with mucosal regeneration and neurosensory support.
Clinical overview of adipose-derived regenerative therapies for Empty Nose Syndrome, comparing microfat, nanofat, SVF and MFAT.